Abstract
Objective Idiopathic inflammatory myopathy-associated interstitial lung disease (IIMILD) can range from rapidly-progressive with high mortality to indolent with minimal morbidity. This systematic review and meta-analysis describes immunological, clinical and radiographical predictors of mortality in IIM-ILD.
Methods MEDLINE and EMBASE database searches were completed on 18/10/21 for articles providing survival data according to baseline characteristics in patients with concurrent IIM and ILD. Prognostic factors common to >5 papers were included in meta-analysis using a random-effects model to report odds ratio for binary variables and hedge's g for continuous variables. Risk of bias was assessed by Newcastle- Ottawa score and Egger's test for publication bias.
Results From 4433 articles, 62 papers were suitable for inclusion, considering 38 different variables. OR for risk of death for anti-MDA-5 was 6.20 (3.58-10.71), and antitRNA- synthetase was protective OR=0.24 (0.14-0.41). ANA, Anti-Ro52 or SS-A did not significantly alter mortality, nor was MDA-5 titre predictive. Age, male gender, acute/sub-acute onset, clinically amyopathic disease, dyspnoea, ulceration, fever, raised CRP, ferritin, LDH, A-aO2 gradient, ground-glass opacities on HRCT and overall HRCT score; and reduced albumin, lymphocytes, PF ratio, %TLCO and %VC are all examples of prognostic factors significantly associated with mortality in this study. Baseline SP-D and KL-6 were not predictors of mortality.
Conclusion Many mortality risk factors were identified, though heterogeneity was high with low quality of evidence and risk of publication bias. Anti-MDA5 disease, and studies from East Asia predominate and may mask risk factors relevant to other IIM subgroups or populations.
Log in using your username and password
Purchase access
In this issue
